COMPARATIVE ANALYSIS OF PERINATAL COMPLICATIONS IN INTRAHEPATIC CHOLESTASIS OF PREGNANT WOMEN
DOI:
https://doi.org/10.31082/1728-452X-2020-219-2220-9-10-28-33Keywords:
Intrahepatic cholestasis, pregnancy, perinatal outcomesAbstract
Intrahepatic cholestasis of pregnancy is associated with a higher incidence of adverse neonatal outcomes, including preterm birth, neonatal respiratory distress syndrome, meconium aspiration syndrome (MAS), and stillborn foetuses. Despite the successes achieved in the problem of Intrahepatic cholestasis of pregnant women (ICPW), a significant number of unfavorable outcomes for the mother and the fetus are associated with insufficiently developed possibilities for predicting them. Unsatisfactory results of pregnancy, childbirth and perinatal indicators, which cause a number of medical and social problems, can be reduced with the availability of effective methods for predicting and, if it, successful prevention and treatment of ICPW.
Purpose of the study. To study the relationship between clinical and laboratory parameters in pregnant women with ICP W with obstetric and perinatal outcomes.
Material and methods. A retrospective analysis of 600 birth histories and exchange cards of pregnant women in the period from 2015 to 2019 with ICPW was carried out, of which 301 pregnant women with intrahepatic cholestasis in the main group, and 299 pregnant women without intrahepatic cholestasis in the control group.
Results and discussion. The most frequent complications of pregnancy and childbirth in ICPW were preterm labor, threatening fetal healthcare, preeclampsia, and postpartum hemorrhage. In patients with ICPW, an increase in the level of hepatic transaminases was significantly associated with a high perinatal risk. Respiratory disorders prevailed in the structure of diseases in newborns. An increase in the incidence of unfavorable neonatal outcomes (fetal distress, low Apgar score, low gestational age) is associated with severe hyperenzymemia in severe forms of ICPW.
Conclusions. An increase in the level of hepatic transaminases is significantly associated with a high perinatal risk. The isolated use of ultrasound doppler in ICPW does not allow to reliably assess the risk of unfavorable perinatal outcomes. Analysis of the results of ultrasound doppler, with an increase in the level of transaminases, is insufficient to assess the degree of risk of antenatal death or a threatening condition of the fetus.
References
Mohan M, Antonios A, Konje J, et al. Stillbirth and associated perinatal outcomes in obstetric cholestasis: a systematic review and meta-analysis of observational studies. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100026. DOI: 10.1016/j.eurox.2019.100026
Klinicheskie rekomendatsii «Vnutripechenochnyi kholestaz pri beremennosti» ot 13.02.2020 № 15-4/367-07. [Clinical guidelines "Intrahepatic cholestasis during pregnancy" dated 13.02.2020 No. 15-4 / 367-07]. Available from: https://prof.ncagp.ru/index.php?_ t8=85
Klinicheskii protokol diagnostiki i lecheniia bolezni pecheni, sviazannye s beremennostiu ot 29.09.2016. – Protokol №12. [Clinical protocol for the diagnosis and treatment of liver disease associated with pregnancy from 09/29/2016]. Available from: http://www.rcrz.kz/docs/ clinic_protocol/2016/2пг/Терапия/Гастроэнтерология/1%20 Болезни%20печени,%20связанные%20с%20беременностью.pdf
Ozkan S, Ceylan Ya, Ozkan OV, Yildirim S. Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2015;21(23):7134-41. DOI: 10.3748/wjg.v21.i23.7134
Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018; 231:180–187. DOI: 10.1016/j. ejogrb.2018.10.041. [Google Scholar] [CrossRef] [PubMed]
Maaroufi A, Vince A, Himatt SM, et al. Historical epidemiology of hepatitis C virus in select countries - volume 4. J Viral Hepat. 2017;24(2):8-24. DOI: 10.1111/jvh.12762
Nersesov AV. Review of the trials on clinical and epidemiologic characteristics of liver diseases, conducted in 2015-2017 in Kazakhstan. Meditsina (Almaty) = Medicine (Almaty). 2017;9(183):4-8. (In Russ.)
Smith DD, Rood KM. Intrahepatic Cholestasis of Pregnancy. Clin Obstet Gynecol. 2020;63(1):134-151. DOI: 10.1097/ GRF.0000000000000495
Ozyuncu O, Orgul G, Ozten G, Yurdakok M, Beksac MS. Outpatient versus inpatient follow-up for intrahepatic cholestasis of pregnancy. Clin Exp Hepatol. 2019;5(4):289–293. DOI: 10.5114/ ceh.2019.88616 [Google Scholar] [CrossRef]
Floreani A, Gervasi MT. New Insights on Intrahepatic Cholestasis of Pregnancy. Clin Liver Dis. 2016;20(1):177–189. DOI: 10.1016/j.cld.2015.08.010. [Google Scholar] [CrossRef]
Polunina TE, Tazitdinov RKh. Intrahepatic cholestasis of pregnant women. Terapiia = Therapy. 2020;6(1):85-95. (In Russ.). DOI: 10.18565/therapy.2020.1.85-95
Klimenchenko NI, et al. Diagnosis and treatment of intrahepatic cholestasis in pregnant women. Clinical guidelines. Akusherstvo i ginekologiia = Obstetrics and gynecology. 2017;1:112-119. (In Russ.). DOI: 10.18565/aig.2017.1.112-119
Hupucнi P, Sziller I, Hruby E, Rigó B, Szabó G, Papp Z. The rate of maternal complications in 107 pregnancies complicated with HELLP syndrome. Orv Hetil. 2006;147(29):1377–85
Ovadia C, Seed PT, Sklavounos A, Geenes V. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174): 899–909. DOI: 10.1016/S0140-6736(18)31877-4. [Google Scholar] [CrossRef]
Uspenskaya YuB, Sheptulin AA, Kuznetsova IV. Risk factors and features of treatment biliary sludge during pregnancy. Consilium Medicum = Consilium Medicum. 2018;20(6):37–40. (In Russ.). DOI: 10.26442/2075-1753_2018.6.37-40
